Parkinson's Disease Psychosis

Acadia's surprise Nuplazid snag—and subsequent cold shoulder at FDA—beg more questions than answers
Fierce Pharma
Wed, 03/10/21 - 11:17 am
Acadia Pharmaceuticals
FDA
Nuplazid
Parkinson's Disease Psychosis
Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis
Xconomy
Fri, 12/6/19 - 09:28 pm
Acadia Pharmaceuticals
cilnical trials
Parkinson's Disease Psychosis
dementia-related psychosis
Acadia Pharma Soars After FDA Investigation Clears Nuplazid of Additional Safety Problems
BioSpace
Fri, 09/21/18 - 11:25 am
Acadia
FDA
Nuplazid
Parkinson's Disease Psychosis
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
CP Wire
Mon, 09/10/18 - 11:43 am
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
Parkinson's Disease Psychosis
CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid
CP Wire
Mon, 04/9/18 - 09:44 am
Acadia
Nuplazid
Parkinson's Disease Psychosis
CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid
Mon, 04/9/18 - 09:43 am
Acadia
Nuplazid
Parkinson's Disease Psychosis
Acadia launches Parkinson’s campaign to shine light on psychosis symptoms
Fierce Pharma
Mon, 11/27/17 - 10:16 am
Acadia
Parkinson's Disease
Parkinson's Disease Psychosis
drug ads
U.S. approves first drug for psychosis linked to Parkinson's
Yahoo/Reuters
Sat, 04/30/16 - 10:42 am
Parkinson's Disease Psychosis
FDA
Acadia
Nuplazid
Acadia: Approval Likely For Parkinson's Disease Psychosis Drug
Seeking Alpha
Wed, 04/13/16 - 11:56 am
Acadia
Parkinson's Disease Psychosis
pimavanserin
Why Biogen Should Acquire ACADIA Pharmaceuticals
Bidness, ETC
Thu, 03/31/16 - 10:06 am
Biogen
Acadia
M&A
Parkinson's Disease Psychosis
Nuplazid
FDA advisers back first drug intended to treat psychotic symptoms of Parkinson's disease
Yahoo/AP
Tue, 03/29/16 - 10:24 pm
FDA
Parkinson's Disease Psychosis
Acadia
advisory panels
pimavanserin
It could reduce hallucinations, but at what cost? New Parkinson’s drug raises questions
Stat
Tue, 03/29/16 - 11:09 am
Parkinson's Disease Psychosis
Nuplazid
Acadia
FDA's internal review of Acadia's Parkinson's drug raises safety, benefit concerns
Fierce Biotech
Sat, 03/26/16 - 12:41 pm
FDA
Acadia
Parkinson's Disease Psychosis
Nuplazid
FDA staff backs Acadia's drug to treat psychosis associated with Parkinson's disease
Yahoo/Reuters
Fri, 03/25/16 - 09:37 am
FDA
Acadia
Parkinson's Disease Psychosis
Nuplazid
Acadia Drug Is Delayed Again as CEO Announces Retirement
TheStreet.com
Wed, 03/11/15 - 08:28 pm
Acadia
Nuplazid
Parkinson's Disease Psychosis
Acadia On Track With Pimavanserin Development Program
Yahoo/Zacks.com
Wed, 08/6/14 - 09:50 am
Acadia
pimavanserin
earnings
Parkinson's Disease Psychosis
Acadia And Parkinson's Treatment Hopes
Seeking Alpha
Mon, 10/14/13 - 08:49 am
Parkinson's Disease
Acadia
pimavanserin
Parkinson's Disease Psychosis
Shares of Acadia Pharma jump on confidence a top drug candidate will be approved
Yahoo/AP
Tue, 03/26/13 - 10:27 am
Acadia
pimavanserin
Parkinson's Disease Psychosis
Acadia Rockets Into The Stratosphere On Clinical Trial Data
Seeking Alpha
Wed, 11/28/12 - 10:59 am
clinical trials
Acadia
pimavanserin
Parkinson's Disease Psychosis
Acadia climbs as company says pimavanserin reduced psychosis in Parkinson's disease patients
Yahoo/AP
Tue, 11/27/12 - 11:16 am
Acadia
Parkinson's Disease
pimavanserin
Parkinson's Disease Psychosis

Pages